Byetta
exenatide — GLP-1 receptor agonist by AstraZeneca
GLP-1subcutaneous injectionTwice daily (within 60 min before meals)FDA Approved
Reviewed by Dr. Elena Vance, DOLast reviewed 5 sources cited
FDA-Approved Indications
- Type 2 diabetes mellitus (adjunct to diet and exercise)
Dosing
| Route | subcutaneous injection |
| Frequency | Twice daily (within 60 min before meals) |
| Starting Dose | 5 mcg twice daily |
| Maintenance | 10 mcg twice daily |
| Max Dose | 10 mcg twice daily |
| Titration | 5 mcg twice daily x 1 month → 10 mcg twice daily based on clinical response. |
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Nausea | 44% | 3/5 |
| Vomiting | 13% | 3/5 |
| Diarrhea | 13% | 2/5 |
| Headache | 9% | 1/5 |
| Dizziness | 9% | 2/5 |
| Dyspepsia | 6% | 2/5 |
| Jittery feeling | 4% | 1/5 |
| Pancreatitis (rare) | <1% | 5/5 |
Cost
| List Price | $800-$900/month |
| With Insurance | $25-$100/month (varies by plan) |
| Savings Card | Limited savings programs available |
Pricing last updated 2026-04-14. Actual costs vary by pharmacy, insurance plan, and location.
Compare Byetta With
Sources & References
FDA & Regulatory
Clinical Trial Records
Peer-Reviewed Literature
Manufacturer Information
Reference Entries
This content is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions. See our full medical disclaimer.